Literature DB >> 30712645

Low complication rates using high power (45-50 W) for short duration for atrial fibrillation ablations.

Roger A Winkle1, Sanghamitra Mohanty2, Rob A Patrawala3, R Hardwin Mead3, Melissa H Kong3, Gregory Engel3, Jonathan Salcedo3, Chintan G Trivedi2, Carola Gianni2, Pierre Jais4, Andrea Natale2, John D Day5.   

Abstract

BACKGROUND: Many centers use radiofrequency (RF) energy at 25-35 W for 30-60 seconds. There is a safety concern about using higher power, especially on the posterior wall.
OBJECTIVE: The purpose of this study was to examine complication rates for atrial fibrillation (AF) ablations performed with high-power, short-duration RF energy.
METHODS: We examined the complication rates of 4 experienced centers performing AF ablations at RF powers from 45-50 W for 2-15 seconds per lesion. In total, 13,974 ablations were performed in 10,284 patients. On the posterior wall, 11,436 ablations used 45-50 W for 2-10 seconds, and 2538 ablations used power reduced to 35 W for 20 seconds. Esophageal temperature monitoring was used in 13,858 (99.2%).
RESULTS: Demographics were age 64 ± 11 years, male 68%, left atrial size 4.4 ± 0.7 cm, paroxysmal AF 37%, persistent AF 42%, longstanding AF 20%, antiarrhythmic drugs failed 1.4 ± 0.7, hypertension 54%, diabetes 15%, previous cerebrovascular accident/transient ischemic attack 7%, and CHA2DS2-VASc score 2.1 ± 1.4. Procedural time was 116 ± 41 minutes. Complications were death in 2 (0.014%; 1 due to stroke and 1 due to atrioesophageal fistula), pericardial tamponade in 33 (0.24%; 26 tapped, 7 surgical), strokes <48 hours in 6 (0.043%), strokes 48 hours-30 days in 6 (0.043%), pulmonary vein stenosis requiring intervention in 2 (0.014%), phrenic nerve paralysis in 2 (0.014%; both resolved), steam pops 2 (0.014%) without complications, and catheter char 0 (0.00%). There was 1 atrioesophageal fistula in 11,436 ablations using power 45-50 W on the posterior wall and 3 in 2538 ablated with 35 W on the posterior wall (P = .021), although 2 of the 3 had no esophageal monitoring during a fluoroless procedure.
CONCLUSION: AF ablations can be performed at 45-50 W for short durations with very low complication rates. High-power, short-duration ablations have the potential to shorten procedural and total RF times and create more localized and durable lesions.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablation complications; Atrial fibrillation; Atrioesophageal fistula; High-power; Short-duration radiofrequency ablation

Mesh:

Year:  2019        PMID: 30712645     DOI: 10.1016/j.hrthm.2018.11.031

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  38 in total

1.  Catheter ablation or surgery to eliminate longstanding persistent atrial fibrillation.

Authors:  Rajan L Shah; Junaid A B Zaman; Sanjiv M Narayan
Journal:  Int J Cardiol       Date:  2019-12-27       Impact factor: 4.164

2.  [Pulmonary vein isolation using radiofrequency ablation].

Authors:  Leon Iden; Sonia Busch; Daniel Steven; Roland R Tilz; Dong-In Shin; K R Julian Chun; Heidi Estner; Felix Bourier; David Duncker; Philipp Sommer; Andreas Metzner; Tilman Maurer; Nils-Christian Ewertsen; Henning Jansen; Andreas Rillig; Victoria Johnson; Till Althoff
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-07-26

Review 3.  [Atrial fibrillation : Recent studies and new treatment options].

Authors:  Leonard Bergau; Christian Sohns; Philipp Sommer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-11-13

4.  Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation.

Authors:  Dibbendhu Khanra; Abdul Hamid; Saurabh Deshpande; Anindya Mukherjee; Sanjiv Petkar; Mohammad Saeed; Indranill Basu-Ray
Journal:  Anatol J Cardiol       Date:  2022-01       Impact factor: 1.596

Review 5.  Catheter ablation for atrial fibrillation: current indications and evolving technologies.

Authors:  Ramanathan Parameswaran; Ahmed M Al-Kaisey; Jonathan M Kalman
Journal:  Nat Rev Cardiol       Date:  2020-10-13       Impact factor: 32.419

6.  Rationale and study design for ablation of paroxysmal atrial fibrillation guided by ablation index: a multi-center, prospective randomized trial (PAF-AI trial).

Authors:  Ruhong Jiang; Minglong Chen; Jie Fan; Fu Yi; Anli Tang; Xingpeng Liu; Wenqing Zhu; Shaowen Liu; Xiaobo Huang; Weizhu Ju; Xi Zhang; Jie Li; Jiangui He; Liang Shi; Genqing Zhou; Yuegang Wang; Chenyang Jiang
Journal:  J Interv Card Electrophysiol       Date:  2020-05-11       Impact factor: 1.900

7.  Feasibility and safety of pulmonary vein isolation by high-power short-duration radiofrequency application: short-term results of the POWER-FAST PILOT study.

Authors:  Sergio Castrejón-Castrejón; Marcel Martínez Cossiani; Marta Ortega Molina; Carlos Escobar; Consuelo Froilán Torres; Nerea Gonzalo Bada; Marta Díaz de la Torre; José Manuel Suárez Parga; José Luis López Sendón; José Luis Merino
Journal:  J Interv Card Electrophysiol       Date:  2019-11-12       Impact factor: 1.900

8.  High Power Ultra Short Duration Ablation with HD Grid Improves Freedom from Atrial Fibrillation and Redo Procedures Compared to Circular Mapping Catheter.

Authors:  Brian Crandall; Sriharsha Kanuri; Michael Cutler; Jeffrey Osborn; Jared Miller; Charles Mallender; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2020-08-31

Review 9.  Efficiency, Safety, and Efficacy of High-Power Short-Duration Radiofrequency Ablation in Patients with Atrial Fibrillation.

Authors:  Xuerong Sun; Jiang Lu; Jinxuan Lin; Tianjie Feng; Ni Suo; Lihui Zheng; Zhimin Liu; Gang Chen; Xiaohan Fan; Shu Zhang; Guodong Niu
Journal:  Cardiol Res Pract       Date:  2021-02-15       Impact factor: 1.866

10.  Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study.

Authors:  Roland Richard Tilz; Makoto Sano; Julia Vogler; Thomas Fink; Roza Saraei; Vanessa Sciacca; Bettina Kirstein; Huong-Lan Phan; Sascha Hatahet; Lisbeth Delgado Lopez; Anna Traub; Charlotte Eitel; Michael Schlüter; Karl-Heinz Kuck; Christian-Hendrik Heeger
Journal:  Int J Cardiol Heart Vasc       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.